Submitted by Anonymous (not verified) on 25 July 2025 - 15:08
Human medicines European public assessment report (EPAR): Hetronifly, serplulimab, Date of authorisation: 03/02/2025, Revision: 3, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Hetronifly, serplulimab, Date of authorisation: 03/02/2025, Revision: 3, Status: Authorised